Literature DB >> 9434158

DNA topoisomerase II cleavage of telomeres in vitro and in vivo.

H J Yoon1, I Y Choi, M R Kang, S S Kim, M T Muller, J R Spitzner, I K Chung.   

Abstract

In this work, we have analyzed the reactivity of DNA topoisomerase II with telomeric DNA both in vitro and in vivo. Topoisomerase II cleavage reactions were performed on the tandem repeats of telomeric DNA. Analysis of this DNA on sequencing gels revealed that DNA topoisomerase II is catalytically active in cleaving the telomere DNA repeat. The topoisomerase II cleavage site is 5'TTAGG*G3' (cleavage site marked by the asterisk) and since telomere DNA is a tandem array of the above sequence, topoisomerase cleavage sites could exist every six base pairs. Detection of topoisomerase II cleavages was strongly dependent upon one specific topoisomerase II poison, etoposide (VP-16). A number of other topoisomerase II poisons were tested but did not stimulate cleavage activity at the telomere repeat. We have also analyzed the association of endogenous topoisomerase II with chromosomal telomeric DNA in HeLa cells. The in vivo complex of enzyme (ICE) bioassay was used to isolate topoisomerase II-DNA covalent complexes. In consistence with in vitro cleavage data, endogenous topoisomerase II-telomeric DNA complexes were detected in only etoposide-treated HeLa cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9434158     DOI: 10.1016/s0167-4781(97)00139-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Rapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA-damaging drug etoposide.

Authors:  T J Moriarty; S Dupuis; C Autexier
Journal:  Leukemia       Date:  2002-06       Impact factor: 11.528

3.  A novel topoisomerase II poison GL331 preferentially induces DNA cleavage at (C/G)T sites and can cause telomere DNA damage.

Authors:  C C Lee; T S Huang
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

4.  Sequence-specific recognition and cleavage of telomeric repeat (TTAGG)(n) by endonuclease of non-long terminal repeat retrotransposon TRAS1.

Authors:  T Anzai; H Takahashi; H Fujiwara
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

5.  Interaction of human DNA topoisomerase I with G-quartet structures.

Authors:  P B Arimondo; J F Riou; J L Mergny; J Tazi; J S Sun; T Garestier; C Hélène
Journal:  Nucleic Acids Res       Date:  2000-12-15       Impact factor: 16.971

6.  Telomerase-associated protein 1, HSP90, and topoisomerase IIalpha associate directly with the BLM helicase in immortalized cells using ALT and modulate its helicase activity using telomeric DNA substrates.

Authors:  Saumitri Bhattacharyya; Jeremy Keirsey; Beatriz Russell; Juraj Kavecansky; Kate Lillard-Wetherell; Kambiz Tahmaseb; John J Turchi; Joanna Groden
Journal:  J Biol Chem       Date:  2009-03-27       Impact factor: 5.157

7.  Nucleostemin prevents telomere damage by promoting PML-IV recruitment to SUMOylated TRF1.

Authors:  Joseph K Hsu; Tao Lin; Robert Y L Tsai
Journal:  J Cell Biol       Date:  2012-05-28       Impact factor: 10.539

8.  Induction of unique structural changes in guanine-rich DNA regions by the triazoloacridone C-1305, a topoisomerase II inhibitor with antitumor activities.

Authors:  Krzysztof Lemke; Marcin Wojciechowski; William Laine; Christian Bailly; Pierre Colson; Maciej Baginski; Annette K Larsen; Andrzej Skladanowski
Journal:  Nucleic Acids Res       Date:  2005-10-27       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.